Skip to main content
High RiskFDAfda-F-0037-2015CONTAMINATION

Bumble Bee Jalapeno Albacore Tuna with Jalapeno & Olive Oil, Net Wt. 2.5oz, UPC 5763800428

Category
Units Affected
188,185
Recall Date
October 6, 2014
Issuing Agency
Hazard
Contamination

FDA Recall Notice

Source: U.S. Food and Drug Administration (FDA) — official FDA notice for recall FDA-F-0037-2015.

Bumble Bee Foods, LLC, has issued a recall on specific codes of pouched Albacore tuna due to defects in the pouch seals which could result in product contamination by spoilage organisms or pathogens, and could lead to illness if consumed.

Corrective Action (per FDA)

Source: U.S. Food and Drug Administration (FDA) — official FDA notice for recall FDA-F-0037-2015.

Recall terminated by FDA.

✅ What you should do

  1. Stop using the product if you own it.
  2. Check the model number, lot code, or sell-by date against the recall notice above.
  3. Contact Bumble Bee Foods Llc or the retailer where you bought it for a refund, replacement, or repair.
  4. For the most current official instructions, visit the FDA recall page.
  5. If you've been hurt by this product, report the incident to FDA.

Consumer Contact (per FDA)

Source: U.S. Food and Drug Administration (FDA) — official FDA notice for recall FDA-F-0037-2015.

Bumble Bee Foods LLC

FDA

About the U.S. Food and Drug Administration

The FDA regulates drugs, medical devices, food, cosmetics, and tobacco. Adverse event reports and recall notices are the main public safety signal.

Visit FDA.gov →

📣 Report a food, supplement, or cosmetic problem to the FDA

If you had a reaction, found contamination, or experienced a labeling problem with this product, report it to the FDA. The agency uses consumer reports to track emerging safety signals and trigger recalls.

How to report to FDAFile a report at FDA

Bumble Bee Foods Llc Recall FAQ

Bumble Bee Foods Llc is the subject of a seafood safety report: Bumble Bee Jalapeno Albacore Tuna with Jalapeno & Olive Oil, Net Wt. 2.5oz, UPC 5763800428. The notice was published on October 6, 2014 by the U.S. Food and Drug Administration (FDA). Approximately 188,185 units are potentially affected.